HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

SLXP: Salix Pharmaceuticals Ltd - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
SALIX PHARMACEUTICALS LTD (NASD)
SLXP 23.40 -0.06 (-0.26%) Vol.  359,852 14:17 ET
Last 23.40 Bid / Size 23.39x200
Net  -0.06 Ask / Size 23.42x300
% Change  -0.26 52 Wk High 24.29
High 23.86 52 Wk Low 6.14
Low 22.99 Volume 359,852
 
Insider Ownership 3.67% S&P 500 Member NO
Institutional Ownership 78.73% Beta .79
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 5.13
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding 49,344,000
Market Capitalization 1,154,649,600
Last Split Date 07/13/2004
Split Factor 1.5
Short Interest Ratio 5.31
 
% Change
4 Weeks 14.44
12 Weeks 86.93
52 Weeks 200.38
 
% Change Relative to S&P 500
4 Weeks 11.68
12 Weeks 73.87
52 Weeks 117.24

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research